Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PDCD11 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PDCD11 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of PDCD11 mRNA | affects expression | 21346803
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of PDCD11 mRNA | decreases expression | 15282401
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PDCD11 mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PDCD11 mRNA | affects cotreatment|affects expression | 17602206
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of PDCD11 mRNA | decreases expression | 16243910
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
4.34 | 7525203 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.62 | 17418594 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.99 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.30 | 18056438 19052882 16434500 17162532 19061943 17620307 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.28 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.28 | 17369602 16935488 11325840 15136595 16595493 15634643 15993339 18628466 17983394 16322301 18382427 19526202 18234424 15939500 15692762 16096432 15994142 15567936 16826403 16264153 16115903 18695136 15668708 17426702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.89 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.89 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.89 | 19171122 18971187 16569478 19519916 17138121 20007298 19052882 16878318 19539802 20432363 18393292 19335982 17978847 19107877 16288022 19418558 17428255 18056438 17173139 18494052 19919837 16698587 20514400 16502159 16807293 20101231 19701751 18978308 10672840 18691550 17761372 19822196 16935385 20084675 19208518 19394651 20214788 16830150 20935162 18665156 18210153 20727157 18785209 10737359 17055752 20512989 3084413 21159647 18506893 17162532 20524982 16328049 18788625 16779866 16681979 19383236 3581430 11831363 16540662 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.89 | 18059187 16023760 17876044 16234567 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.27 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 17382496 16278810 15505089 16952015 15792986 16455267 16364871 17308081 16731534 17924179 18627295 17928571 15811867 17974986 17131338 17007740 17329180 16242529 17519947 16612575 15476868 16269455 16651473 17351982 16109756 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.78 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.31 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.31 | 7505956 17174075 21159647 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.93 | 19052882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.41 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.12 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.12 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.24 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.80 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.80 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
12.80 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.80 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.80 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.87 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.56 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.46 | 20387270 21071580 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 16495754 12587719 18006777 16330681 17875725 17888722 16879835 16144979 14766674 16244371 16244372 18674790 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.50 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.65 | 15147373 18501091 17606976 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.50 | 18785209 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15369732 15699352 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.15 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.15 | 16705839 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.96 | 19638242 20032147 18522880 18665156 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16595196 16439617 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.15 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
8.04 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
8.04 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
8.04 | 20501860 21278145 19427195 19426721 19255062 20452335 19642983 20101389 19073162 19690152 20405173 12112319 21071580 19812893 18978307 12771043 19850985 20137499 19551842 15175105 2862719 18648771 20434301 19499222 21167192 19254457 20492335 9163691 19090486 19256749 2422723 19638242 20583210 18754104 16942905 18644402 15885732 19833225 10737359 21047994 20118626 18977376 19294768 19996281 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.86 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.86 | 17854601 18079962 17942915 3124819 19539802 18775883 16267830 18544905 19009564 18093689 16842330 18282651 19004024 21159647 9362446 2563599 18253720 19126423 17174075 19519916 18308698 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.86 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.65 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.65 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.04 | 15857846 19429709 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.70 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.70 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
6.19 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.19 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 15640375 16889571 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.39 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.57 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.56 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
16.75 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
16.75 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
16.75 | 14694615 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.50 | 16540662 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.80 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.51 | 15897917 16868541 16888761 15749863 18437689 16729912 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 18313854 16767912 17710206 17203757 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.47 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.47 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.06 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 16767912 15625365 17203757 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
8.00 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.00 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.89 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.89 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.89 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.35 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.35 | 10091137 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17678736 16364871 17334414 17638931 |